Randomized controlled trial to improve care for urban children with asthma: results of the School-Based Asthma Therapy trial

Arch Pediatr Adolesc Med. 2011 Mar;165(3):262-8. doi: 10.1001/archpediatrics.2011.1.


Objective: To evaluate the impact of the School-Based Asthma Therapy trial on asthma symptoms among urban children with persistent asthma.

Design: Randomized trial, with children stratified by smoke exposure in the home and randomized to a school-based care group or a usual care control group.

Setting: Rochester, New York.

Participants: Children aged 3 to 10 years with persistent asthma.

Interventions: Directly observed administration of daily preventive asthma medications by school nurses (with dose adjustments according to National Heart, Lung, and Blood Institute Expert Panel guidelines) and a home-based environmental tobacco smoke reduction program for smoke-exposed children, using motivational interviewing.

Main outcome measure: Mean number of symptom-free days per 2 weeks during the peak winter season (November-February), assessed by blinded interviews.

Results: We enrolled 530 children (74% participation rate). During the peak winter season, children receiving preventive medications through school had significantly more symptom-free days compared with children in the control group (adjusted difference = 0.92 days per 2 weeks; 95% confidence interval, 0.50-1.33) and also had fewer nighttime symptoms, less rescue medication use, and fewer days with limited activity (all P < .01). Children in the treatment group also were less likely than those in the control group to have an exacerbation requiring treatment with prednisone (12% vs 18%, respectively; relative risk = 0.64; 95% confidence interval, 0.41-1.00). Stratified analyses showed positive intervention effects even for children with smoke exposure (n = 285; mean symptom-free days per 2 weeks: 11.6 for children in the treatment group vs 10.9 for those in the control group; difference = 0.96 days per 2 weeks; 95% confidence interval, 0.39-1.52).

Conclusions: The School-Based Asthma Therapy intervention significantly improved symptoms among urban children with persistent asthma. This program could serve as a model for improved asthma care in urban communities.

Trial registration: ClinicalTrials.gov NCT00296998.

Publication types

  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Albuterol / analogs & derivatives
  • Albuterol / therapeutic use
  • Androstadienes / therapeutic use
  • Asthma / drug therapy
  • Asthma / prevention & control*
  • Bronchodilator Agents / therapeutic use*
  • Child
  • Child, Preschool
  • Cotinine / analysis
  • Counseling
  • Directly Observed Therapy*
  • Female
  • Fluticasone
  • Home Care Services*
  • Humans
  • Indicators and Reagents / analysis
  • Inhalation Spacers
  • Linear Models
  • Male
  • New York
  • Saliva / chemistry
  • Salmeterol Xinafoate
  • School Health Services*
  • Seasons
  • Tobacco Smoke Pollution / prevention & control*
  • Urban Population


  • Androstadienes
  • Bronchodilator Agents
  • Indicators and Reagents
  • Tobacco Smoke Pollution
  • Salmeterol Xinafoate
  • Fluticasone
  • Cotinine
  • Albuterol

Associated data

  • ClinicalTrials.gov/NCT00296998